MAPT and Alzheimer disease: GSK-3α has been implicated in the amyloidogenic processing of APP to yield Aβ peptides [12], while GSK-3β has been implicated in the tau-related pathogenesis of AD, by colocalizing with tau tangles and phosphorylating tau [9].